Posted by Michael Wonder on 08 Sep 2020
U.S. FDA approves Athena Bioscience's new drug application for Qdolo (tramadol hydrochloride) oral solution
8 September 2020 - FDA approved Qdolo (tramadol hydrochloride), an oral liquid, accommodates dosing flexibility, precise titration.
Athena Bioscience announced today that the U.S. FDA has approved Qdolo (tramadol hydrochloride) 5 mg/mL oral solution C-IV, an opioid agonist indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
